Home » Topics » Regulatory » Patents

Patents
RSS

Merck & Co. reveals new series of tachykinin antagonists

Oct. 18, 1996

Nissan Chem. claims hypoglycemic agents for diabetes

Oct. 11, 1996

New hepatoprotectants from Nisshin Flour Milling

Oct. 11, 1996

Zenyaku Kogyo discloses anti-Helicobacter pylori agents

Oct. 11, 1996

Integrin receptor antagonists described by SKB

Oct. 11, 1996

Antiplatelet fibrinogen antagonists from Yamanouchi

Oct. 11, 1996

Fibrinogen antagonist research continues at Merck & Co.

Oct. 11, 1996

MTP inhibitors from Bristol-Myers Squibb

Oct. 11, 1996

Wakunaga discloses angiotensin II antagonists

Oct. 11, 1996

Endothelin antagonists from Banyu

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...